A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Patient charts will be reviewed to evaluate the incidence of intraocular pressure spikes
while on Loteprednol etabonate ophthalmic suspension 0.5%, Loteprednol etabonate (0.5%) and
tobramycin (0.3%)